亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

50 Circulating genomic biomarkers predict chemoradiotherapy resistance and immunotherapy response in locally advanced non-small cell lung cancer

放化疗 免疫疗法 肺癌 医学 肿瘤科 癌症研究 癌症 内科学
作者
Yu Wang,Tao Zhang,Jianyang Wang,Lühua Wang,Nan Bi
出处
期刊: 卷期号:: A56-A56
标识
DOI:10.1136/jitc-2024-sitc2024.0050
摘要

Background

Efficacy of curative-intent chemoradiotherapy (CRT) and consolidation immune checkpoint inhibitor (ICI) is heterogenous in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). Effective biomarkers to early identify resistance to CRT and guide risk-adaptive consolidation immunotherapy are urgently needed. The clinical value of STK11 (LKB1) and KEAP1 alterations in NSCLC remains controversial, since patients with these theoretically resistance-related mutations exhibited favorable ICI benefits.

Methods

In this prospective cohort trial (NCT06287320), patients with unresectable stage II-III NSCLC were assigned to the CRT or CRT plus consolidation ICI groups. Peripheral blood samples were collected at longitudinal landmark timepoints, including pretreatment, during-CRT, post-CRT, and at disease progression, to profile circulating tumor DNA (ctDNA) dynamics and genomic features. Blood-based tumor genotyping was performed using pretreatment plasma and leukocytes. An independent cohort of ctDNA molecular residual disease (MRD) testing from 87 LA-NSCLC patients receiving CRT alone or CRT + consolidation ICI was employed for external validation. Whole genome or whole exome sequencing from 421 LA-NSCLC patients and RNA-sequencing data from 1,149 patients were used for tumor tissue-based validation and mechanism exploration.

Results

A total of 239 blood samples from 73 patients, including 36 with CRT and 37 with CRT plus ICI, were analyzed. Pretreatment blood-based STK11/KEAP1 alterations were associated with poorer prognosis and CRT resistance but additional survival benefits from consolidation immunotherapy. In the ctDNA-MRD validation cohort, STK11/KEAP1 mutations could early identify inferior outcomes with CRT but significantly favorable consolidation ICI responses. Tumor tissue genomic profiling confirmed STK11/KEAP1 alterations were poor prognostic factors correlated with resistance to definitive CRT. RNA sequencing revealed STK11/KEAP1-mutated tumors were characterized by immunosuppressive phenotype before treatment, particularly strikingly decreased Th17 cells in the tumor microenvironment through IL-17 signaling downregulation, which might result in impaired anti-tumor immune responses to upfront treatments but improved efficacy of consolidation ICI by activating local anti-tumor immunity after definitive radiotherapy. Although patients with undetectable ctDNA MRD post CRT had excellent outcomes irrespective of consolidation ICI, the subgroup with STK11/KEAP1 alterations effectively benefited from further ICI therapy, highlighting baseline STK11/KEAP1 as a potential remedy for false negatives generated by individual ctDNA-MRD detection.

Conclusions

STK11/KEAP1 alterations were correlated with poor prognosis and resistance to upfront CRT, but identified more benefits from consolidation ICI therapy. Considering genomic features in the context of liquid biopsy biomarkers could facilitate more personalized treatment decisions.

Acknowledgements

We are grateful to all patients and their families who participated in this study.

Trial Registration

This biomarker study was and registered at ClinicalTrials.gov (NCT06287320).

Ethics Approval

This study was approved by the Ethics Committee of Chinese Academy of Medical Sciences (No. 19/098-1883).

Consent

Written informed consent was obtained from the patient for publication of this abstract and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
感性的远航完成签到,获得积分10
8秒前
刻苦的刚完成签到,获得积分10
16秒前
年轻靖巧完成签到,获得积分10
31秒前
33秒前
朝花惜拾完成签到 ,获得积分10
39秒前
搜集达人的应助被科研通管家采纳,获得10
1分钟前
奔跑的应助被科研通管家采纳,获得10
1分钟前
迷路飞凤完成签到,获得积分10
1分钟前
1分钟前
漂亮的又槐完成签到,获得积分10
1分钟前
1分钟前
1分钟前
英俊的铭的应助被小小昌采纳,获得10
1分钟前
1分钟前
1分钟前
噗愣噗愣地刚发芽完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
大胆紫烟完成签到,获得积分10
1分钟前
SEN完成签到,获得积分10
2分钟前
陶醉的傲霜完成签到,获得积分10
2分钟前
ccob完成签到,获得积分10
2分钟前
2分钟前
2分钟前
liujing_242022完成签到,获得积分10
2分钟前
2分钟前
dnpl完成签到,获得积分10
2分钟前
2分钟前
温婉的安彤完成签到,获得积分10
2分钟前
SEN关注了科研通微信公众号
2分钟前
自觉的猕猴桃完成签到,获得积分10
2分钟前
Orange的应助被糊涂的初柔采纳,获得10
2分钟前
2分钟前
酷酷云朵完成签到,获得积分10
2分钟前
3分钟前
369ninja的应助被科研通管家采纳,获得10
3分钟前
奔跑的应助被科研通管家采纳,获得10
3分钟前
奔跑的应助被科研通管家采纳,获得10
3分钟前
SEN发布了新的文献求助10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179877
求助须知:如何正确求助?哪些是违规求助? 9570060
关于积分的说明 21808221
捐赠科研通 7775626
什么是DOI,文献DOI怎么找? 3433171
关于科研通互助平台的介绍 2557308
邀请新用户注册赠送积分活动 2478846